(2023)
[Assessment of direct (COVID-19-Related) and collateral, psychosocial pandemic consequences for vulnerable groups by the example of serious mental illness].
Psychiatr Prax 50(7),
381-388.
Marie von Lilienfeld-Toal
National Reference Center for Invasive Fungal Infections Infections in Hematology/Oncology +49 3641 532-1720 marie.lilienfeld-toal@leibniz-hki.deCurriculum vitae
Main Research Areas
- Tumour and infection immunology
- Epidemiology of infections of von Infektionen immunosuppressed patients
- Clinical diagnostic and therapeutical studies
Professional Career
| 2014 | Deputy head of the Nationales Referenzzentrum für invasive Pilzinfektionen |
| 2013 | W2-professorship in infection research in haematology and oncology, medical faculty, Friedrich-Schiller University Jena |
| 2010 | Habilitation in internal medicine, Rheinische Friedrich-Wilhelms University Bonn |
| 2008-2013 | Senior physician in the dept. haematology / oncology (med. clinic III), University Hospital, Bonn |
| 2007-2008 | EBMT Fellowship Bone Marrow Transplantation Programme, Leeds, UK |
| 2007 | Acceptance of the priority area haematology / oncology |
| 2006 | Specialist in internal diseases |
| 2003-2004 | Gerok fellowship within the BonFor funding programme, medical faculty Bonn |
| 1999-2007 | Doctor in practical training (AiP) /assistant physician in internal medicine, University Hospital Bonn |
| 1999 | PhD in clinical pharmacology, „magna cum laude“, medical faculty, Rheinische Friedrich-Wilhelms University Bonn |
| 1998 | Staatsexamen (state examination) human medicine |
Awards · Appointments · Scientific Activities
| Since 2013 | Member of the ethics commission, medical faculty of the FSU Jena |
| Since 2013 | Board member of the working group dealing with infections in haematology and oncology (AGIHO) of the Deutsche Gesellschaft für Hämatologie und internistische Onkologie (DGHO) |
| Since 2008 | Member of the AGIHO |
| 2008-2010 | Assistant lecturer at the medical clinic III of the University Hospital Bonn |
| 2002-2006 | Member of the statutes commission of the medical faculty of the Rheinische Friedrich-Wilhelms University Bonn |
| 2009 | Best abstract DGHO |
| 2008 | Poster award |
| Since 2004 | Assessor of several magazines |
Publications
(2023)
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9).
Leukemia 37(9),
1933-1938.
(2023)
AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants.
Eur J Cancer 181,
102-118.
(Review)
(2023)
The lipid raft-associated protein stomatin is required for accumulation of dectin-1 in the phagosomal membrane and for full activity of macrophages against Aspergillus fumigatus.
mSphere 8(1),
e00523-22.
(2023)
Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP).
Infection 52(1),
93-104.
(2022)
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety.
Nat Rev Clin Oncol 19(6),
385-401.
(Review)
(2022)
Invasive aspergillosis-on-chip: A quantitative treatment study of human Aspergillus fumigatus infection.
Biomaterials 283,
121420.
(2022)
The TLR-NF-kB axis contributes to the monocytic inflammatory response against a virulent strain of Lichtheimia corymbifera, a causative agent of invasive mucormycosis.
Front Immunol 13,
882921.
(2021)
Human mucosal-associated invariant T cells respond to Mucorales species in a MR1-dependent manner.
Med Mycol 59(5),
505-509.
(2021)
Evidence-based management of COVID-19 in cancer patients: Guideline by the infectious diseases working party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Eur J Cancer 140,
86-104.
